Literature DB >> 15818648

Opportunistic infections in polymyositis and dermatomyositis.

Isabelle Marie1, Eric Hachulla, Patrick Chérin, Marie-France Hellot, Serge Herson, Hervé Levesque, Pierre-Yves Hatron.   

Abstract

OBJECTIVE: To assess prevalence and characteristics of opportunistic infections in patients with polymyositis/dermatomyositis (PM/DM). To determine the predictive values for opportunistic infections on clinical presentation, biochemical findings, and paraclinical features of PM/DM to detect patients at risk of opportunistic infections.
METHODS: The medical records of 156 consecutive PM/DM patients in 3 medical centers were reviewed.
RESULTS: Eighteen PM/DM patients (11.5%) developed opportunistic infections. The majority of patients exhibited an opportunistic infection after the onset of PM/DM (89% of cases). Opportunistic infections occurred most frequently during the first year following PM/DM diagnosis (62.5%). The pathogen microorganisms responsible for opportunistic infections were various, i.e., Candida albicans, Pneumocystis carinii, Aspergillus fumigatus, Geotrichum capitatum, Mycobacterium avium-intracellulare complex, M. xenopi, M. marinum, M. tuberculosis, Helicobacter heilmanii, cytomegalovirus, and herpes simplex virus. Mortality rates were as high as 27.7% in these PM/DM patients. Higher mean daily doses of steroids, lymphopenia, and lower serum total protein levels were significantly more frequent in the group of PM/DM patients with opportunistic infections.
CONCLUSION: Our study underscores the high frequency of opportunistic infections in PM/DM, resulting in an increased mortality rate. It also indicates that a great variety of microorganisms are responsible for opportunistic infections, although they were more often due to fungi (>50% of cases). Our series highlights a predominance of both lung and digestive opportunistic infections (89% of cases). In addition, our results suggest that PM/DM patients presenting with factors predictive of opportunistic infection may require closer monitoring.

Entities:  

Mesh:

Year:  2005        PMID: 15818648     DOI: 10.1002/art.21083

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  28 in total

1.  Interstitial Lung Disease in Idiopathic Inflammatory Myopathy.

Authors:  Lesley Ann Saketkoo; Dana P Ascherman; Vincent Cottin; Lisa Christopher-Stine; Sonye K Danoff; Chester V Oddis
Journal:  Curr Rheumatol Rev       Date:  2010-05

Review 2.  Infection-related morbidity and mortality in patients with connective tissue diseases: a systematic review.

Authors:  Matthew E Falagas; Katerina G Manta; Gregoria I Betsi; Georgios Pappas
Journal:  Clin Rheumatol       Date:  2006-12-21       Impact factor: 2.980

3.  Refractory polymyositis undergoing remission following antitubercular therapy.

Authors:  Durga Prasanna Misra; Sukesh Edavalath; Abhra Chandra Chowdhury; Vikas Agarwal
Journal:  BMJ Case Rep       Date:  2015-04-22

Review 4.  Myositis-related interstitial lung disease and antisynthetase syndrome.

Authors:  Joshua Solomon; Jeffrey J Swigris; Kevin K Brown
Journal:  J Bras Pneumol       Date:  2011 Jan-Feb       Impact factor: 2.624

5.  Mycophenolate mofetil: a possible therapeutic agent for children with juvenile dermatomyositis.

Authors:  Kelly A Rouster-Stevens; Gabrielle A Morgan; Deli Wang; Lauren M Pachman
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-10       Impact factor: 4.794

Review 6.  Pneumocystis Pneumonia and the Rheumatologist: Which Patients Are At Risk and How Can PCP Be Prevented?

Authors:  Rachel M Wolfe; James E Peacock
Journal:  Curr Rheumatol Rep       Date:  2017-06       Impact factor: 4.592

7.  A population-based study of infection-related hospital mortality in patients with dermatomyositis/polymyositis.

Authors:  Sara G Murray; Gabriela Schmajuk; Laura Trupin; Erica Lawson; Matthew Cascino; Jennifer Barton; Mary Margaretten; Patricia P Katz; Edward H Yelin; Jinoos Yazdany
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-05       Impact factor: 4.794

8.  [Therapy of myositis].

Authors:  A D Keck; U A Walker
Journal:  Z Rheumatol       Date:  2013-04       Impact factor: 1.372

Review 9.  Diagnosis and management of infectious complications of childhood rheumatic diseases.

Authors:  Rhina D Castillo; Wendy De la Pena; Katherine A B Marzan
Journal:  Curr Rheumatol Rep       Date:  2013-04       Impact factor: 4.592

10.  Concomitant diseases in a cohort of patients with idiopathic myositis during long-term follow-up.

Authors:  K P Ng; F Ramos; S M Sultan; D A Isenberg
Journal:  Clin Rheumatol       Date:  2009-04-23       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.